Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Decreased Cardiac Ejection Fraction Is Associated with Worse Survival in Patients with Light Chain Amyloidosis Treated with Autologous Stem Cell Transplantation

Abdullah S. Al Saleh, MBBS, Iuliana Vaxman, MDBA, Harsh Parmar, MD, Alissa Visram, MD, M Hasib Sidiqi, MBBS, Eli Muchtar, MD, Francis K. Buadi, MB, CHB, David Dingli, MD PhD, Martha Q. Lacy, MD, Rahma M Warsame, MD, Wilson I Gonsalves, MD, Taxiarchis Kourelis, MD, William J Hogan, MB, BCh, Prashant Kapoor, MD, Robert Wolf, PharmD, RPh, Angela Dispenzieri, MD, Shaji K. Kumar, MD, Morie A. Gertz, MD

Blood (2020) 136 (Supplement 1): 41–42.

https://doi.org/10.1182/blood-2020-143076

Published: 2020

Journal Articles

Presence of a Measurable M-Spike before Autologous Stem Cell Transplantation Is Associated with Shorter Survival in Patients with Light Chain Amyloidosis

Abdullah S. Al Saleh, MBBS, Iuliana Vaxman, MDBA, Harsh Parmar, MD, M Hasib Sidiqi, MBBS, Eli Muchtar, MD, Francis K. Buadi, MB, CHB, David Dingli, MD PhD, Martha Q. Lacy, MD, Rahma M Warsame, MD, Wilson I Gonsalves, MD, Taxiarchis Kourelis, MD, William J Hogan, MB, BCh, Prashant Kapoor, MD, Robert Wolf, PharmD, RPh, Angela Dispenzieri, MD, Shaji K. Kumar, MD, Morie A. Gertz, MD

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-143125

Published: 2020

Journal Articles

Risk Factors for Increased Length of Stay (LOS) in Patients with Hematological Malignancies Electively Admitted for Chemotherapy

Christopher E. Wee, MD, Jilan Kubusek, PharmD, Irbaz Riaz, MDMMSc, Robert Wolf, PharmD, RPh, Julian R Molina, MD PhD, Naseema Gangat, MBBS

Blood (2019) 134 (Supplement_1): 2138.

https://doi.org/10.1182/blood-2019-127367

Published: 2019

Journal Articles

Stem Cell Transplant without Growth Factor In Multiple Myeloma: Engraftment Kinetics, Bacteremia, and Hospitalization.

Morie Abraham Gertz, MD, Dennis Gastineau, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Suzanne R. Hayman, MD, Shaji Kumar, MD, David Dingli, M.D., Ph.D., Nelson Leung, MD, Robert Wolf, PharmD, RPh, William J Hogan, MBBCh, Francis Buadi, MD

Blood (2010) 116 (21): 3469.

https://doi.org/10.1182/blood.V116.21.3469.3469

Published: 2010

Journal Articles

Transplantation for Immunoglobulin Light Chain Amyloidosis. A Statistical Analysis of Factors Predicitng Outcome In Over 400 Patients

Morie Abraham A. Gertz, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Shaji Kumar, MD, Francis Buadi, MD, David Dingli, M.D., Ph.D., Stephen M. Ansell, MD, PhD, Dennis Gastineau, MD, David James Inwards, MD, Patrick B Johnston, MD, PhD, Mark R. Litzow, MD, Ivana Micallef, MD, Luis Porrata, MD, Nelson Leung, MD, Robert Wolf, PharmD, RPh, William J Hogan, MBBCh, Suzanne R. Hayman, MD

Blood (2010) 116 (21): 3557.

https://doi.org/10.1182/blood.V116.21.3557.3557

Published: 2010

NARROW

Decreased Cardiac Ejection Fraction Is Associated with Worse Survival in Patients with Light Chain Amyloidosis Treated with Autologous Stem Cell Transplantation

Presence of a Measurable M-Spike before Autologous Stem Cell Transplantation Is Associated with Shorter Survival in Patients with Light Chain Amyloidosis

Risk Factors for Increased Length of Stay (LOS) in Patients with Hematological Malignancies Electively Admitted for Chemotherapy

Stem Cell Transplant without Growth Factor In Multiple Myeloma: Engraftment Kinetics, Bacteremia, and Hospitalization.

Transplantation for Immunoglobulin Light Chain Amyloidosis. A Statistical Analysis of Factors Predicitng Outcome In Over 400 Patients

Email alerts

ASH Publications

American Society of Hematology

Decreased Cardiac Ejection Fraction Is Associated with Worse Survival in Patients with Light Chain Amyloidosis Treated with Autologous Stem Cell Transplantation

Presence of a Measurable M-Spike before Autologous Stem Cell Transplantation Is Associated with Shorter Survival in Patients with Light Chain Amyloidosis

Risk Factors for Increased Length of Stay (LOS) in Patients with Hematological Malignancies Electively Admitted for Chemotherapy

Stem Cell Transplant without Growth Factor In Multiple Myeloma: Engraftment Kinetics, Bacteremia, and Hospitalization.

Transplantation for Immunoglobulin Light Chain Amyloidosis. A Statistical Analysis of Factors Predicitng Outcome In Over 400 Patients

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only